Clinical Trial Update: Study That Will Evaluate the Brazilian Population With COPD.

View source ↗

Summary

AstraZeneca is conducting a clinical trial to evaluate COPD in the Brazilian population, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Status: RECRUITING